Global Virology Market 2021 - Industry Statistics

December 2021 | 83 pages | ID: G5235D172464EN
Gen Consulting Company

Abstracts

Virology is the scientific discipline concerned with the study of the biology of viruses and viral diseases, including the distribution, biochemistry, physiology, molecular biology, ecology, evolution and clinical aspects of viruses. Projected to expand at a CAGR of 5.1% from 2021 to 2027, the global virology market will worth USD 4,711 million by 2027-end, according to Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global virology market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The virology market is segmented on the basis of type, application, end user, and region. The virology market is segmented as below:

By type:

• diagnosing test
• viral infection controlling methods
• antiviral therapeutics
• interferons

By application:

• skin & soft tissue infections
• respiratory tract infections
• GI tract infections
• sexually transmitted diseases
• urinary tract infection
• others

By end user:

• hospitals
• diagnostic laboratories
• pharmaceutical & biotechnological companies
• research & academic institutes

By region:

• region
• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The global virology market report offers detailed information on several market vendors, including Abbott Laboratories, AbbVie Inc., F. Hoffmann-La Roche AG, Gilead Sciences, Inc., GlaxoSmithKline plc, Illumina, Inc., Johnson and Johnson, QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global virology market.
• To classify and forecast the global virology market based on type, application, end user, and region.
• To conduct pricing analysis for the global virology market.
• To identify and analyze the profile of leading players operating in the global virology market.

Why Choose This Report

• Gain a reliable outlook of the global virology market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. GLOBAL MARKET FOR VIROLOGY BY TYPE

4.1 Diagnosing test
  4.1.1 Market size and forecast
4.2 Viral infection controlling methods
  4.2.1 Market size and forecast
4.3 Antiviral therapeutics
  4.3.1 Market size and forecast
4.4 Interferons
  4.4.1 Market size and forecast

PART 5. GLOBAL MARKET FOR VIROLOGY BY APPLICATION

5.1 Skin & soft tissue infections
  5.1.1 Market size and forecast
5.2 Respiratory tract infections
  5.2.1 Market size and forecast
5.3 GI tract infections
  5.3.1 Market size and forecast
5.4 Sexually transmitted diseases
  5.4.1 Market size and forecast
5.5 Urinary tract infection
  5.5.1 Market size and forecast
5.6 Others
  5.6.1 Market size and forecast

PART 6. GLOBAL MARKET FOR VIROLOGY BY END USER

6.1 Hospitals
  6.1.1 Market size and forecast
6.2 Diagnostic laboratories
  6.2.1 Market size and forecast
6.3 Pharmaceutical & biotechnological companies
  6.3.1 Market size and forecast
6.4 Research & academic institutes
  6.4.1 Market size and forecast

PART 7. GLOBAL MARKET FOR VIROLOGY BY REGION

7.1 Asia Pacific
  7.1.1 Market size and forecast
7.2 Europe
  7.2.1 Market size and forecast
7.3 North America
  7.3.1 Market size and forecast
7.4 Rest of the World (RoW)
  7.4.1 Market size and forecast

PART 8. MARKET SHARE ANALYSIS

8.1 Abbott Laboratories
8.2 AbbVie Inc.
8.3 F. Hoffmann-La Roche AG
8.4 Gilead Sciences, Inc.
8.5 GlaxoSmithKline plc
8.6 Illumina, Inc.
8.7 Johnson and Johnson
8.8 QIAGEN N.V.
8.9 Siemens Healthineers AG
8.10 Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER

ABOUT GEN CONSULTING COMPANY